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General Experimental  
All reagents were purchased from Sigma-Aldrich or AlfaAesar and were used as received 
without further purification. Where described below petrol refers to petrol (b.p. 40-60 °C). All 
reactions were monitored by thin-layer chromatography (TLC) on pre-coated SIL G/UV254 
silica gel plates (254 m) purchased from VWR. Flash column chromatography was carried 
out with Kiesegel 60M 0.04/0.063 mm (200-400 mesh) silica gel. 
1
H and 
13
C NMR spectra 
were recorded at ambient temperature on a Bruker Avance 600 instrument operating at a 
frequency of 600 MHz for 
1
H and 150 MHz for 
13
C in a deuterated solvent as described below. 
The chemical shifts () for 1H and 13C are quoted relative to residual signals of the solvent on 
the ppm scale. 
1
H NMR peaks are reported as singlet (s), doublet (d), triplet (t), quartet (q), 
quintet (quintet), broad (br) or multiplet (m). Coupling constants (J values) are reported in 
Hertz (Hz) and are H-H coupling constants unless otherwise stated. Signal multiplicities in 
13
C 
NMR were determined using the distortionless enhancement by phase transfer (DEPT) spectral 
editing technique. Infrared spectra were obtained on a Perkin Elmer Spectrum 100 FTIR 
Spectrometer operating in ATR mode with frequencies given in reciprocal centimetres (cm
-1
). 
Melting points were measured with a Gallenkamp apparatus and are uncorrected. Mass spectra 
were obtained on a VG70-SE mass spectrometer. Optical rotations were measured using a 
Perkin Elmer 343 polarimeter.  
 
LC-MS was performed on protein samples using a Thermo Scientific uPLC connected to MSQ 
Plus Single Quad Detector (SQD). Column: Hypersil Gold C4, 1.9 µm 2.1 x 50 mm. 
Wavelength: 254 nm. Mobile Phase: 99:1 Water:MeCN (0.1% formic acid) to 1:9 Water: 
MeCN (0.1% formic acid) gradient over 4 min. Flow Rate: 0.3 mL/min. MS Mode: ES
+
. Scan 
Range: m/z = 500-2000. Scan time: 1.5 s. Data obtained in continuum mode. The electrospray 
source of the MS was operated with a capillary voltage of 3.5 kV and a cone voltage of 50 V. 
Nitrogen was used as the nebulizer and desolvation gas at a total flow of 600 L/h. Ion series 
were generated by integration of the total ion chromatogram (TIC) over the 3.5-5.0 min range. 
Total mass spectra for protein samples were reconstructed from the ion series using the pre-
installed ProMass software.  
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 3,4-Dibromo-furan-2,5-dione
1
 
 
A mixture of maleic anhydride (1.50 g, 15.3 mmol), AlCl3 (28 mg, 0.21 mmol) and Br2 (1.57 
mL, 4.89 g, 30.6 mmol) was heated at 160 ºC in a sealed ampoule for 20 h. After this time, the 
reaction mixture was allowed to cool to room temperature, and diluted with EtOAc (25 mL). 
The reaction mixture was then filtered and the solid washed thoroughly with EtOAc (3 × 25 
mL). The filtrate was then concentrated in vacuo to afford 3,4-dibromo-furan-2,5-dione as a 
yellow solid (3.25 g, 12.8 mmol, 83%): m.p. 107-110 °C (lit. m.p. 113-114 °C)
1
; 
13
C NMR 
(MeOD, 150 MHz) δ 164.4 (C), 125.9 (C); IR (solid) 1769, 1706, 1590 cm-1. 
 
3,4-Dibromo-1-phenyl-pyrrole-2,5-dione 1
1
 
 
To a solution of 3,4-dibromo-furan-2,5-dione (0.50 g, 1.97 mmol) in AcOH (25 mL) was 
added aniline (0.18 mL, 1.97 mmol), and the reaction mixture stirred at room temperature for 
3 h and then at 130 °C for 90 min. After this time, the solvents were removed in vacuo, with 
the residual traces of AcOH removed by azeotropic distillation using toluene (3 × 25 mL). The 
crude residue was purified by flash column chromatography (5% EtOAc/petrol) to afford 3,4-
dibromo-1-phenyl-pyrrole-2,5-dione 1 as a pale yellow solid (0.37 g, 1.12 mmol, 57%): m.p. 
158-160 °C (lit. m.p. 162-163 °C)
1
; 
1
H NMR (CDCl3, 600 MHz) δ 7.48-7.47 (2H, m, ArH), 
7.44-7.40 (1H, m, ArH), 7.33 (2H, d, J = 7.2 Hz, ArH); 
13
C NMR (CDCl3, 150 MHz) δ 163.0 
(C), 132.8 (C), 130.8 (C), 129.5 (CH), 128.8 (CH), 126.2 (CH); IR (solid) 3058, 1727, 1715, 
1646, 1610, 1598, 1501 cm
-1
; LRMS (EI) 333 (50, [M
81
Br
81
Br]
+
), 331 (100, [M
81
Br
 79
Br]
+
), 
329 (50, [M
79
Br
 79
Br]
+
); HRMS (EI) calcd for C10H5O2NBr2 [M
79
Br
 79
Br]
+
 328.8682, observed 
328.8685. 
 
3,4-Bis-ethylsulfanyl-1-phenyl-pyrrole-2,5-dione 2 
 
To a solution of 3,4-dibromo-1-phenyl-pyrrole-2,5-dione 1 (237 mg, 0.72 mmol) in CH2Cl2 (30 
mL) was added ethanethiol (0.11 mL, 1.50 mmol) and NEt3 (0.21 mL, 1.50 mmol), and the 
reaction mixture stirred at room temperature for 15 min. After this time, the solvents were 
removed in vacuo and the crude residue purified by flash column chromatography (5% 
EtOAc/petrol) to afford 3,4-bis-ethylsulfanyl-1-phenyl-pyrrole-2,5-dione 2 as a yellow oil (195 
mg, 0.66 mmol, 93%): 
1
H NMR (CDCl3, 600 MHz) δ 7.48-7.44 (2H, m, ArH), 7.37-7.33 (3H, 
m, ArH), 3.37 (4H, q, J = 7.4 Hz, CH3CH2S), 1.38 (6H, t, J = 7.4 Hz, CH3CH2S); 
13
C NMR 
(CDCl3, 150 MHz) δ 165.5 (C), 135.7 (C), 131.6 (C), 129.2 (CH), 128.0 (CH), 126.2 (CH), 
26.5 (CH2), 15.8 (CH3); IR (neat) 2965, 2926, 2851, 1706, 1598, 1501 cm
-1
; LRMS (EI) 293 
(100, [M]
+
); HRMS (EI) calcd for C14H15O2NS2 [M]
+
 293.0539, observed 293.0540. 
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 Lithium 2,3-bis-ethylsulfanyl-3-phenylcarbamoyl-acrylate 3 
 
To a solution of 3,4-bis-ethylsulfanyl-1-phenyl-pyrrole-2,5-dione 2 (19.0 mg, 0.065 mmol) in a 
1:1 mixture of CD3OD:D2O (1 mL:1 mL) was added LiOH.H2O (146 mg, 3.48 mmol) and the 
reaction mixture stirred at room temperature for 24 h to afford lithium 2,3-bis-ethylsulfanyl-3-
phenylcarbamoyl-acrylate 3: 
1
H NMR (CD3OD/D2O, 600 MHz) δ 7.46 (2H, d, J = 7.8 Hz, 
ArH), 7.38 (2H, t. J = 7.8 Hz, ArH), 7.18 (1H, t, J = 7.8 Hz, ArH), 2.90 (2H, q, J = 7.5 Hz, 
CH3CH2S), 2.80 (2H, q, J = 7.5 Hz, CH3CH2S), 1.31 (3H, t, J = 7.5 Hz, CH3CH2S), 1.29 (3H, 
t, J = 7.5 Hz, CH3CH2S); 
13
C NMR (CD3OD/D2O, 150 MHz) δ 171.7 (C), 166.0 (C), 156.9 
(C), 139.6 (C), 130.3 (CH), 126.3 (C), 122.7 (CH), 119.9 (CH), 28.9 (CH2), 28.0 (CH2), 15.7 
(CH3), 15.3 (CH3). 
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3,4-Bis-ethylsulfanyl-furan-2,5-dione 4 
 
To a solution of lithium 2,3-bis-ethylsulfanyl-3-phenylcarbamoyl-acrylate 3 (0.065 mmol) in a 
1:1 mixture of CD3OD:D2O (1 mL:1 mL) was added 2M HCl and the reaction mixture 
acidified to pH 4. After this, 3,4-bis-ethylsulfanyl-furan-2,5-dione 4 was extracted from the 
reaction mixture into EtOAc (3 × 20 mL), washed with sat. NaCl, dried (MgSO4), filtered and 
the solvents removed in vacuo to afford 3,4-bis-ethylsulfanyl-furan-2,5-dione 4 as an oil (14.0 
mg, 0.065 mmol, >99%% over two steps): 
1
H NMR (CDCl3, 600 MHz) δ 3.37 (4H, q, J = 7.4 
Hz, CH3CH2S), 1.36 (6H, t, J = 7.4 Hz, CH3CH2S); 
13
C NMR (CDCl3, 150 MHz) δ 160.4 (C), 
136.9 (C), 26.4 (CH2), 15.7 (CH3); IR (neat) 2969, 2930, 1761, 1518 cm
-1
; LRMS (EI) 218 
(100, [M]
+
); HRMS (EI) calcd for C8H10O3S2 [M]
+
 218.0066, observed 218.0071. 
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3,4-Dibromo-2,5-dioxo-2,5-dihydro-pyrrole-1-carboxylic acid methyl ester 5
2
 
 
To a solution of 3,4-dibromo-furan-2,5-dione (1.0 g, 3.9 mmol) and N-methylmorpholine (0.43 
mL, 3.9 mmol) in THF (35 mL) was added methyl chloroformate (0.30 mL, 3.9 mmol) and the 
reaction mixture stirred at room temperature for 20 min. After this time, CH2Cl2 (40 mL) was 
added, the organic phase washed with H2O (3 × 40 mL), dried (MgSO4) and the solvent 
removed in vacuo to afford 3,4-dibromo-2,5-dioxo-2,5-dihydro-pyrrole-1-carboxylic acid 
methyl ester 5 as a pink powder (1.18 g, 3.8 mmol, 97%): m.p. 114-116 °C (lit. m.p. 115-
118 °C)
2
; 
1
H NMR (CDCl3, 600 MHz) δ 4.00 (3H, s, CH3); 
13
C NMR (CDCl3, 150 MHz) δ 
159.3 (C), 147.0 (C), 131.5 (C), 54.9 (CH3); IR (solid) 3236, 2962, 1809, 1769, 1730, 1602 
cm
-1
; LRMS (CI) 314 (50, [M
81
Br
81
Br +H]
+
), 312 (100, [M
81
Br
 79
Br]
+
), 310 (50, [M
79
Br
 
79
Br]
+
); HRMS (EI) calcd for C6H3O4NBr2 [M
79
Br
79
Br]
+
 310.8423, observed: 310.8427. 
 
3,4-Dibromo-1-(4-hydroxymethyl-phenyl)-pyrrole-2,5-dione 6
2
 
 
To a solution of 3,4-dibromo-2,5-dioxo-2,5-dihydro-pyrrole-1-carboxylic acid methyl ester 5 
(300 mg, 0.965 mmol) in CH2Cl2 (42 mL) was added 4-aminobenzyl alcohol (119 mg, 0.965 
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mmol), and the reaction mixture stirred at room temperature for 2 h. After this time, the 
solvents were removed in vacuo and the crude residue purified by flash column 
chromatography (50% EtOAc/petrol) to afford 3,4-dibromo-1-(4-hydroxymethyl-phenyl)-
pyrrole-2,5-dione 6 as a yellow solid (345 mg, 0.955 mmol, 99%): m.p. 215-217 °C (lit. m.p. 
217-220 °C)
2
; 
1
H NMR (CDCl3, 600 MHz) δ 7.49 (2H, d, J = 8.4 Hz, ArH), 7.33 (2H, d, J = 
8.4 Hz, ArH), 4.75 (2H, s, CH2OH); 
13
C NMR (CDCl3, 150 MHz) δ 163.0 (C), 141.6 (C), 
130.2 (C), 130.0 (C), 127.8 (CH), 126.3 (CH), 64.7 (CH2); IR (solid) 3364, 1732, 1714, 1610, 
1519 cm
-1
; LRMS (EI) 361 (50, [M
81
Br
81
Br]
+
), 359 (100, [M
81
Br
 79
Br]
+
), 357 (50, [M
79
Br
 
79
Br]
+
); HRMS (EI) calcd for C11H7O3NBr2 [M
79
Br
79
Br]
+
 358.8787, observed: 358.8798. 
 
3,4-Bis-ethylsulfanyl-1-(4-hydroxymethyl-phenyl)-pyrrole-2,5-dione 
 
To a solution of 3,4-dibromo-1-(4-hydroxymethyl-phenyl)-pyrrole-2,5-dione 6 (315 mg, 0.872 
mmol) in CH2Cl2 (40 mL) was added ethanethiol (0.18 mL, 2.33 mmol) and NEt3 (0.33 mL, 
2.33 mmol) and the reaction mixture stirred at room temperature for 1 h. After this time, the 
reaction mixture was concentrated in vacuo and the crude residue purified by flash column 
chromatography (50% EtOAc/petrol) to afford 3,4-bis-ethylsulfanyl-1-(4-hydroxymethyl-
phenyl)-pyrrole-2,5-dione as a yellow solid (242 mg, 0.748 mmol, 86%): m.p. 50-52 ºC; 
1
H 
NMR (CDCl3, 600 MHz) δ 7.45 (2H, d, J = 8.4 Hz, ArH), 7.33 (2H, d, J = 8.4 Hz, ArH), 4.72 
(2H, s, CH2OH), 3.37 (4H, q, J = 7.4 Hz, CH3CH2S), 1.37 (6H, t, J = 7.4 Hz, CH3CH2S); 
13
C 
NMR (CDCl3, 150 MHz) δ 165.5 (C), 140.7 (C), 135.7 (C), 130.9 (C), 127.6 (CH), 126.3 
(CH), 64.9 (CH2), 26.5 (CH2), 15.8 (CH3); IR (solid) 3381, 2967, 2928, 2869, 1702, 1514 cm
-1
; 
LRMS (EI) 323 (100, [M]
+
); HRMS (EI) calcd for C15H17O3NS2 [M]
+
 323.0644, observed: 
323.0634. 
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 Phenyl-carbamic acid 4-(3,4-bis-ethylsulfanyl-2,5-dioxo-2,5-dihydro-pyrrol-1-yl)-benzyl 
ester 7 
 
To a solution of 3,4-bis-ethylsulfanyl-1-(4-hydroxymethyl-phenyl)-pyrrole-2,5-dione (100 mg, 
0.309 mmol) in CH2Cl2 (14 mL) was added phenylisocyanate (0.035 mL, 0.322 mmol) and 
NEt3 (0.091 mL, 0.653 mmol), and the reaction mixture stirred at room temperature for 2 days.  
After this time, the reaction mixture was concentrated in vacuo and the crude residue purified 
by flash column chromatography (20% EtOAc/petrol) to afford phenyl-carbamic acid 4-(3,4-
bis-ethylsulfanyl-2,5-dioxo-2,5-dihydro-pyrrol-1-yl)-benzyl ester 7 as a yellow solid (84 mg, 
0.190 mmol, 62%): m.p. 97-99 ºC; 
1
H NMR (CDCl3, 600 MHz) δ 7.49 (2H, d, J = 8.3 Hz, 
ArHCH2O), 7.39-7.35 (4H, m, ArHCH2O and ArHNH), 7.32-7.30 (2H, m, ArHNH), 7.07 (1H, 
t, J = 7.4 Hz, ArHNH), 6.66 (1H, br s, NH), 5.22 (2H, s, CH2OCONH), 3.37 (4H, q, J = 7.4 
Hz, CH3CH2S), 1.37 (6H, t, J = 7.4 Hz, CH3CH2S); 
13
C NMR (CDCl3, 150 MHz) δ 165.4 (C), 
153.2 (C), 137.7 (C), 135.8 (C), 131.6 (C), 129.2 (CH), 129.1 (CH), 126.3 (CH), 126.2 (CH), 
123.7 (CH), 118.8 (C), 66.4 (CH2), 26.5 (CH2), 15.8 (CH3); IR (solid) 3374, 2964, 2928, 1733, 
1705, 1598, 1532 cm
-1
; LRMS (ESI) 465 (100, [M+Na]
+
); HRMS (ESI) calcd for 
C22H22N2O4NaS2 [M+Na]
+
 465.0919, observed: 465.0923. 
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 3,4-Bis-ethylsulfanyl-furan-2,5-dione 4 and aniline 
 
To a solution of phenyl-carbamic acid 4-(3,4-bis-ethylsulfanyl-2,5-dioxo-2,5-dihydro-pyrrol-1-
yl)-benzyl ester 7 (19.5 mg, 0.044 mmol) in a 1:1 mixture of CD3OD:D2O (0.8 mL:0.8 mL) 
was added LiOH.H2O (102 mg, 2.44 mmol) and the reaction mixture stirred at room 
temperature for 2 h. After this time, 2M HCl was added and the reaction mixture acidified to 
pH 4. Then, 3,4-bis-ethylsulfanyl-furan-2,5-dione 4 was extracted from the reaction mixture 
into EtOAc (3 × 20 mL), washed with sat. NaCl, dried (MgSO4), filtered and the solvents 
removed in vacuo to afford 3,4-bis-ethylsulfanyl-furan-2,5-dione 4 as an oil (9.6 mg, 0.044 
mmol, >99%). Data matched that described above. 
 
The pH 4, aqueous solution was neutralised by addition of 1M NaOH. Then, the organic 
materials were extracted into CHCl3 (3 × 5 mL), dried (MgSO4), filtered and the solvent was 
removed in vacuo. The crude residue was purified by flash column chromatography (10% 
EtOAc/petrol) to afford aniline as an oil (3.9 mg, 0.042 mmol, 95%). 
1
H NMR (CDCl3, 600 
MHz) δ 7.16 (2H, t, J = 8.0 Hz, ArH), 6.77 (1H, t, J = 8.0 Hz, ArH), 6.70 (2H, d, J = 8.0 Hz, 
ArH), 3.84 (2H, br s, NH2); 
13
C NMR (CDCl3, 150 MHz) δ 146.2 (C), 129.4 (CH), 118.9 (CH), 
115.4 (CH); IR (neat) 3445, 3354, 3210, 3068, 3032, 1619, 1602, 1497 cm
-1
. 
 
 
Electronic Supplementary Material (ESI) for Chemical Communications
This journal is © The Royal Society of Chemistry 2013
 
 
1-(4-Hydroxymethyl-phenyl)-3,4-bis-phenylsulfanyl-pyrrole-2,5-dione 8 
 
To a solution of 3,4-dibromo-1-(4-hydroxymethyl-phenyl)-pyrrole-2,5-dione 6 (139 mg, 0.385 
mmol) in CH2Cl2 (18 mL) was added NEt3 (0.145 mL, 1.04 mmol) and phenylthiol (0.08 mL, 
0.809 mmol), and the reaction mixture stirred at room temperature for 30 min. After this time, 
the reaction mixture was concentrated in vacuo and the crude residue purified by flash column 
chromatography (20% EtOAc/petrol) to afford 1-(4-hydroxymethyl-phenyl)-3,4-bis-
phenylsulfanyl-pyrrole-2,5-dione 8 as a yellow solid (159 mg, 0.378 mmol, 98%): m.p. 111-
113 ºC; 
1
H NMR (CDCl3, 600 MHz) δ 7.46 (2H, d, J = 8.4 Hz, ArHCH2OH), 7.32 (2H, d, J = 
8.4 Hz, ArHCH2OH), 7.31-7.26 (10H, m, ArHS), 4.70 (2H, s, CH2OH); 
13
C NMR (CDCl3, 150 
MHz) δ 165.8 (C), 140.7 (C), 135.8 (C), 132.2 (CH), 130.8 (C), 129.2 (CH), 128.8 (C), 128.7 
(CH), 127.6 (CH), 126.1 (CH), 64.9 (CH2); IR (solid) 3388, 3057, 2928, 2874, 1705, 1515 
cm
-1
; LRMS (EI) 419 (100, [M]
+
); HRMS (EI) calcd for C23H17O3NS2 [M]
+
 419.0650, 
observed: 419.0653. 
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 Carbonic acid 4-(2,5-dioxo-3,4-bis-phenylsulfanyl-2,5-dihydro-pyrrol-1-yl)-benzyl ester 4-
nitro-phenyl ester 9 
 
To a solution of 1-(4-hydroxymethyl-phenyl)-3,4-bis-phenylsulfanyl-pyrrole-2,5-dione 8 (30 
mg, 0.071 mmol) in CH2Cl2 (2 mL) was added 4-nitrophenylchloroformate (17 mg, 0.085 
mmol) and pyridine (0.007 mL, 0.085 mmol, and the reaction mixture was stirred at room 
temperature for 24 h. After this time, CH2Cl2 (10 mL) and 10% aqueous citric acid (10 mL) 
were added, the organic phase washed with H2O (10 mL) and sat. NaCl (10 mL), dried 
(MgSO4), filtered and the solvent removed in vacuo. The resultant crude residue was purified 
by flash column chromatography (20% EtOAc/petrol) to afford carbonic acid 4-(2,5-dioxo-3,4-
bis-phenylsulfanyl-2,5-dihydro-pyrrol-1-yl)-benzyl ester 4-nitro-phenyl ester 9 as an oil (30 
mg, 0.051 mmol, 72%): 
1
H NMR (CDCl3, 600 MHz) δ 8.27 (2H, d, J = 8.3 Hz, ArHNO2), 7.49 
(2H, d, J = 8.3 Hz, ArHNO2), 7.40 (2H, d, J = 8.3 Hz, ArHCH2O), 7.37 (2H, d, J = 8.3 Hz, 
ArHCH2O), 7.33-7.26 (10H, m, ArHS), 5.28 (2H, s, CH2OCO2); 
13
C NMR (CDCl3, 150 MHz) 
δ 165.6 (C), 155.5 (C), 152.5 (C), 147.6 (C), 135.9 (C), 133.8 (C), 132.3 (CH), 132.1 (C), 
129.5 (CH), 129.2 (CH), 128.8 (CH), 128.7 (C), 126.2 (CH), 125.5 (CH), 121.9 (CH), 70.3 
(CH2); IR (neat) 3080, 1767, 1714, 1594, 1520 cm
-1
; LRMS (EI) 584 (100, [M]
+
); HRMS (EI) 
calcd for C30H20O7N2S2 [M]
+
 584.0712, observed: 584.0718. 
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{3-Hydroxy-2-methyl-6-[3,5,12-trihydroxy-3-(2-hydroxy-acetyl)-10-methoxy-6,11-dioxo-
1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy]-tetrahydro-pyran-4-yl}-carbamic acid 4-
(2,5-dioxo-3,4-bis-phenylsulfanyl-2,5-dihydro-pyrrol-1-yl)-benzyl ester 10 
 
To a solution of carbonic acid 4-(2,5-dioxo-3,4-bis-phenylsulfanyl-2,5-dihydro-pyrrol-1-yl)-
benzyl ester 4-nitro-phenyl ester 9 (9.8 mg, 0.017 mmol) and DOX·HCl (10 mg, 0.018 mmol) 
in NMP (0.30 mL) was added NEt3 (2.5 µL, 0.018 mmol), and the reaction mixture stirred at 
room temperature for 3 days. After this time, the reaction mixture was diluted with 10% 
i-propanol/EtOAc, washed with H2O (10 mL) and sat. NaCl (10 mL), dried (MgSO4), filtered 
and the solvent removed in vacuo. The crude residue was purified by flash column 
chromatography (2% MeOH/CH2Cl2) to afford {3-Hydrohxy-2-methyl-6-[3,5,12-trihydroxy-3-
(2-hydroxy-acetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy]-
tetrahydro-pyran-4-yl}-carbamic acid 4-(2,5-dioxo-3,4-bis-phenylsulfanyl-2,5-dihydro-pyrrol-
1-yl)-benzyl ester 10 as an orange oil (16.4 mg, 0.0166 mmol, 99%): 
1
H NMR (CDCl3, 600 
MHz) δ 13.96 (1H, s , DOX), 13.22 (1H, s, DOX), 8.02 (1H, d, J = 8.2 Hz, DOX), 7.77 (1H, d, 
J = 8.2 Hz), 7.38 (1H, d, J = 8.2 Hz, DOX), 7.34 (2H, d, J = 8.2 Hz, ArHCH2), 7.31-7.22 (12H, 
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m, ArHCH2 (2H) and ArHS (10H)), 5.49 (1H, br s, DOX), 5.27 (1H, br s, DOX), 5.03-4.98 
(2H, m, DOX), 4.75 (2H, s, CH2O), 4.14-4.10 (1H, m, DOX), 4.07 (3H, s, DOX), 3.86-3.82 
(1H, m, DOX), 3.65 (1H, s, DOX), 3.25 (1H, d, J = 18.7 Hz, DOX), 2.98 (1H, d, J = 18.7 Hz), 
2.32 (1H, d, J = 14.6 Hz, DOX), 2.16 (1H, dd, J = 14.6 and 4.0 Hz, DOX), 1.86 (1H, dd, J = 
13.4 and 4.9 Hz, DOX), 1.79-1.76 (1H, m, DOX), 1.27 (3H, d, J = 6.6 Hz, DOX); 
13
C NMR 
(CDCl3, 150 MHz) δ 214.0 (C), 187.2 (C), 186.8 (C), 165.7 (C), 161.1 (C), 156.3 (C), 155.7 
(C), 155.5 (C), 136.1 (C), 135.9 (C), 135.7 (CH), 135.6 (C), 133.7 (C), 132.2 (CH), 131.2 (C), 
129.2 (CH), 129.2 (CH), 128.9 (CH), 128.9 (C), 128.7 (CH), 125.9 (CH), 120.9 (C), 120.0 
(CH), 118.6 (CH), 111.7 (C), 111.5 (C), 100.8 (CH), 76.7 (C), 69.7 (CH), 69.6 (CH), 67.4 
(CH), 66.1 (CH2), 65.7 (CH2), 56.8 (CH3), 47.1 (CH), 35.7 (CH2), 34.1 (CH2), 30.2 (CH2), 17.0 
(CH3); IR (neat) 3481, 3080, 1716, 1580, 1517 cm
-1
; LRMS (ESI) 1011 (100, [M+Na]
+
); 
HRMS (ESI) calcd for C51H44N2O15NaS2 [M+Na]
+
 1011.2081, observed: 1011.2122; [] 20D = 
+91.3 (c 1.1, CHCl3). 
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Trastuzumab Fab Fragment Preparation 
 
Attempted preparation of a Trastuzumab Fab Fragment using the protocol outlined by 
K. L. Bennett et al.
3
 
 
In accordance with the report by K. L. Bennett et al.,
3
 trastuzumab (6.41 mg/ml) in digestion 
buffer was reacted with a 1/10 amount (wt./wt.) of immobilized papain (250 g/mL of gel) for 
20 h at 37 °C under nitrogen in a buffer containing 20 mM sodium phosphate monobasic, 10 
mM disodium EDTA and 80 mM cysteine.HCl (pH 7.0). The cysteine.HCl was incorporated 
immediately before trastuzumab digestion. After digestion, the mixture was centrifuged at 
200 rcf for 5 min and the supernatant was removed for purification. The supernatant was 
concentrated to a volume of 200 L using a diafiltration column (30 KDa MWCO) to purify it 
from low-molecular-weight proteolytic contaminants, and buffer exchanged into phosphate-
buffered saline (PBS, pH 7.0) by passage through diafiltration columns (30 KDa MWCO) four 
times with excessive PBS (pH 7.0). Finally, the sample was analysed by LCMS and revealed a 
mixture of Fab products, LCMS observed masses: 47306 and 47673. 
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Figure S1. (a) non-deconvoluted and (b) deconvoluted MS data for attempted preparation of a trastuzumab Fab 
fragment using the protocol outlined by K. L. Bennett et al.
3
 
. 
Preparation of trastuzumab Fab fragment (11) using sequential digests with pepsin and 
papain 
 
Immobilized pepsin (0.15 mL) was washed with digestion buffer (20 mM sodium acetate 
trihydrate, pH 3.1) four times and trastuzumab (0.5 mL, 6.41 mg/mL in digestion buffer) was 
added. The mixture was incubated for 5 h at 37 ºC whilst shaking (1100 rpm). The resin was 
separated from the digest using a filter column, and washed with digest buffer (50 mM 
phosphate, 1 mM EDTA, 150 mM NaCl, pH 6.8) three times. The digest was combined with 
the washes and the volume adjusted to 0.5 mL. The sample was analysed by LCMS and 
revealed formation of trastuzumab-F(ab’)2, LCMS observed mass: 97303. 
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Figure S2. (a) non-deconvoluted and (b) deconvoluted MS data for digestion of trastuzumab with pepsin to afford 
trastuzumab-F(ab’)2. 
 
After this, papain (1 mL, 0.25 mg/mL) was activated with 10 mM DTT (in digest buffer: 50 
mM phosphate, 1 mM EDTA, 150 mM NaCl, pH 6.8) under an argon atmosphere whilst 
shaking (1100 rpm) for 1 h at 25 ºC in the dark. The resin was washed with digest buffer 
(without DTT) four times and the 0.5 mL of Herceptin-F(ab’)2 added. The mixture was 
incubated for 16 h at 37 ºC whilst shaking (1100 rpm) in the dark. Then the resin was separated 
from the digest using a filter column, and washed with PBS (pH 7.0) three times. The digest 
was combined with the washes and the buffer was exchanged completely for PBS (pH 7.4) 
using diafiltration columns (10 KDa MWCO) and the volume adjusted to 0.4 mL. The digest 
was analysed by SDS-PAGE and LCMS to reveal formation of a single trastuzumab Fab 
fragment, 11: observed mass 47644. The concentration of trastuzumab Fab fragment 11 was 
determined by UV/VIS using a molecular extinction coefficient of 280 = 68590 M
-1
 cm
-1
. 
[trastuzumab Fab fragment 11] 3.33 mg/mL (0.4 mL), 64%. 
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(c) 
 
Figure S3. (a) non-deconvoluted, (b) deconvoluted MS data, and (c) SDS-PAGE characterisation of trastuzumab 
Fab fragment 11 prepared by using sequential digests with pepsin and papain. 
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Fab ADC Experimental Procedures and Data 
 
Reduced trastuzumab Fab 
 
 
 
To a solution of Fab fragment 11 (50 L, 1.72 mg/mL, 25 mM sodium borate, 25 mM NaCl, 
1 mM EDTA, pH 8.0) was added TCEP (15L, 0.36 mM) to affect reduction of the interchain 
disulfide. After 1.5 h at 37 °C, the reaction mixture was analysed by LCMS to reveal the heavy 
and light chains only (i.e. reduced trastuzumab Fab fragment). 
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Figure S4. (a) non-deconvoluted and (b) deconvoluted MS data for reduction trastuzumab Fab fragment 11 with 
TCEP. 
 
Trastuzumab Fab-DOX ADC 12 
 
 
 
To the solution of reduced trastuzumab Fab fragment 11 was added MeCN (13 L, 20% v/v), 
DMF (6.5 L, 10% v/v) and {3-Hydroxy-2-methyl-6-[3,5,12-trihydroxy-3-(2-hydroxy-acetyl)-
10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-1-yloxy]-tetrahydro-pyran-4-yl}-
carbamic acid 4-(2,5-dioxo-3,4-bis-phenylsulfanyl-2,5-dihydro-pyrrol-1-yl)-benzyl ester 10 
(1.15 L, 7.91 mM in DMF), and the reaction maintained at 37 °C for 1 h. After this time, the 
reaction mixture was analysed by LCMS to reveal formation of desired trastuzumab Fab-DOX 
ADC 12 (expected mass: 48414 Da, observed mass: 48413 Da). 
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Figure S5. (a) non-deconvoluted and (b) deconvoluted MS data for trastuzumab Fab-DOX ADC 12. 
 
Trastuzumab Fab-DOX ADC 13 
 
 
 
The solution of trastuzumab Fab-DOX ADC 12 was prepared as described above, and then 
buffer exchanged into PBS (pH 7.4, final volume: 50 µL), and the solution incubated for 20 h 
at 37 °C. After this time, the reaction mixture was analysed by LCMS to reveal formation of 
partial maleimide hydrolysis product trastuzumab Fab-DOX ADC 13 (expected mass: 48432 
Da, observed mass: 48433 Da). The only degradation product (expected mass: 48036 Da, 
observed mass: 48031 Da) observed corresponded to that resulting from the known hydrolysis 
of the sugar component of DOX upon prolonged incubation.
4
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Figure S6. (a) non-deconvoluted and (b) deconvoluted MS data for trastuzumab Fab-DOX ADC 13. 
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 Stability of trastuzumab Fab-DOX ADC (13) at physiological pH and temperature 
 
Trastuzumab Fab-DOX ADC 13 was incubated at physiological temperature and pH (PBS, pH 
7.4, final volume: 50 µL) for 3 days. During this time, no degradation of the linker was 
observed by LCMS.  
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Figure S7. (a) non-deconvoluted and (b) deconvoluted MS data for trastuzumab Fab-DOX ADC 13 at 
physiological pH and temperature after 3 days. 
 
Release of DOX from ADC 13 at lysosomal pH to yield Conjugate 14 
 
 
 
The solution of trastuzumab Fab-DOX ADC 13 was prepared as described above and then 
buffer exchanged into a low pH buffer (50 mM citric acid, 150 mM sodium chloride, pH 4.5) 
by ultrafiltration. The solution was incubated at 37 ºC. Aliquots of the reaction mixture were 
analysed by LCMS after 2, 6, 24, 48 and 72 h. Near quantitative release of the cargo was 
observed (expected mass: 47740 Da, observed mass: 47740 Da). 
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(b) 
2h 
Figure S8. (a) non-deconvoluted and (b) deconvoluted MS data for trastuzumab Fab-DOX ADC 13 at pH 4.5 and 
37 ºC after 2 h. 
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Figure S9. (a) non-deconvoluted and (b) deconvoluted MS data for trastuzumab Fab-DOX 
ADC 13 at pH 4.5 and 37 ºC after 6 h. 
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Figure S10. (a) non-deconvoluted and (b) deconvoluted MS data for trastuzumab Fab-DOX ADC 13 at pH 4.5 
and 37 ºC after 24 h. 
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Figure S11. (a) non-deconvoluted and (b) deconvoluted MS data for trastuzumab Fab-DOX ADC 13 at pH 4.5 
and 37 ºC after 48 h. 
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Figure S12. (a) non-deconvoluted and (b) deconvoluted MS data for trastuzumab Fab-DOX ADC 13 at pH 4.5 
and 37 ºC after 72 h. 
 
Preparation of processed trastuzumab Fab 
 
A solution of Fab fragment 11 (50 L, 1.72 mg/mL, 25 mM sodium borate, 25 mM NaCl, 1 
mM EDTA, pH 8.0) was incubated for 1.5 h at 37 °C. After this time, to the solution were 
added MeCN (13 L, 20% v/v) and DMF (6.5 L, 10% v/v) and the reaction maintained at 
37 °C for 1 h. Next, the reaction mixture was buffer exchanged into PBS (pH 7.4, final 
volume: 50 µL), and the solution incubated for 20 h at 37 °C. After this time, the reaction 
mixture was analysed by LCMS to reveal processed Fab (expected mass: 47644 Da, observed 
mass: 47650 Da). 
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Figure S13. (a) non-deconvoluted and (b) deconvoluted MS data for processed trastuzumab Fab. 
 
Protocol for ELISA 
 
96-Well plates were coated overnight at 4 ºC with HER2 (0.25 μg/mL); PBS was used as 
negative control. HER2 was removed; the wells washed with PBS and blocked with 200 μL of 
1% BSA solution for 2 h at room temperature. After washing with PBS, the serially diluted test 
samples (30 nM, 10 nM, 3.33 nM, 1.11 nM, 0.37 nM, 0.12 nM) were added and incubated for 
1 h at room temperature. The wells were washed twice with PBS-T (PBS, 0.1% Tween-20) and 
once with PBS, and anti-human IgG, Fab-specific-HRP antibody (Sigma-Aldrich) was 
incubated for 1 h at room temperature to detect the bound test sample. The plates were washed 
again and 100 μL of 0.5 mg/mL o-phenylenediamine hydrochloride (Sigma-Aldrich) in a 
phosphate-citrate buffer with sodium perborate were added as substrate. Once colour was 
visible, the reaction was stopped by acidifying with 50 μL of 4M HCl. Absorbance was 
immediately measured at 490 nm. ELISA assays were conducted for trastuzumab Fab 11, 
processed Fab and Fab ADC 13. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S14. 1 ELISA analysis of Fab 11, processed Fab and Fab ADC 13 binding to the HER2 antigen. 
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